96 related articles for article (PubMed ID: 3080240)
1. Leukemia derived growth factors produced by human malignant T-lymphoid cell lines.
Uittenbogaart CH; Nishanian PG; Anisman DJ; Erikson TK; Fahey JL
Cancer Res; 1986 Mar; 46(3):1219-23. PubMed ID: 3080240
[TBL] [Abstract][Full Text] [Related]
2. Constitutive production of B cell differentiation factor-like activity by human T and B cell lines.
Kanowith-Klein S; Saxon A; Uittenbogaart CH
Eur J Immunol; 1987 May; 17(5):593-8. PubMed ID: 3495441
[TBL] [Abstract][Full Text] [Related]
3. Membrane characteristics of established human T- and B-cell lines. Cross-reactivity of human T-antigenic determinants with peripheral lymphocytes of non-human primates and the presence of MLC antigens on cultured T-cell lines.
Takada A; Babbitt H; Hayata I; Takada Y
Clin Exp Immunol; 1976 Apr; 24(1):81-95. PubMed ID: 59650
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of a B cell growth inhibitory factor (BIF) on BCGF-dependent B cell proliferation.
Kawano M; Iwato K; Kuramoto A
J Immunol; 1985 Jan; 134(1):375-81. PubMed ID: 3871108
[TBL] [Abstract][Full Text] [Related]
5. Leukemia-derived growth factor (non-interleukin 2) produced by a human malignant T lymphoid cell line.
Uittenbogaart CH; Fahey JL
Proc Natl Acad Sci U S A; 1982 Nov; 79(22):7004-8. PubMed ID: 6983693
[TBL] [Abstract][Full Text] [Related]
6. Strong, specific anti-human leukemia antisera prepared with the use of purified cell membrane antigen.
Negoro S; Seon BK
Cancer Res; 1981 Jul; 41(7):2973-6. PubMed ID: 6972802
[TBL] [Abstract][Full Text] [Related]
7. A novel cell growth-promoting factor identified in a B cell leukemia cell line, BALL-1.
Dao T; Holán V; Minowada J
Neoplasma; 1993; 40(5):265-73. PubMed ID: 8272154
[TBL] [Abstract][Full Text] [Related]
8. Disparity of mixed lymphocyte reactivity to cultured cells of human T and B lymphoid lines.
Pauly JL; Minowada J; Han T; Moore GE
J Natl Cancer Inst; 1975 Mar; 54(3):557-62. PubMed ID: 123598
[TBL] [Abstract][Full Text] [Related]
9. Dissociation in the production of B cell-stimulating factors (BCGF and BCDF) and interleukin 2 by T cells from a common variable immunodeficient patient.
Saiki O; Shimizu M; Saeki Y; Kishimoto S; Kishimoto T
J Immunol; 1984 Oct; 133(4):1920-4. PubMed ID: 6088629
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibody SN2 defining a human T cell leukemia-associated cell surface glycoprotein.
Seon BK; Negoro S; Barcos MP; Tebbi CK; Chervinsky D; Fukukawa T
J Immunol; 1984 Apr; 132(4):2089-95. PubMed ID: 6607954
[TBL] [Abstract][Full Text] [Related]
11. Human lymphocyte differentiation antigens HB-10 and HB-11. I. Ontogeny of antigen expression.
Tedder TF; Clement LT; Cooper MD
J Immunol; 1985 May; 134(5):2983-8. PubMed ID: 3156922
[TBL] [Abstract][Full Text] [Related]
12. A subclone of the CEM cell line produces human B cell growth factor activity.
Ligler FS
Lymphokine Res; 1984; 3(4):183-91. PubMed ID: 6333568
[No Abstract] [Full Text] [Related]
13. Determinants of deoxyadenosine toxicity in hybrids between human T- and B- lymphoblasts as a model for the development of drug resistance in T-cell acute lymphoblastic leukemia.
Kurtzberg J; Hershfield MS
Cancer Res; 1985 Apr; 45(4):1579-86. PubMed ID: 3872167
[TBL] [Abstract][Full Text] [Related]
14. A case of human B cell leukemia that implicates an autocrine mechanism in the abnormal growth of Leu 1 B cells.
Kawamura N; Muraguchi A; Hori A; Horii Y; Mutsuura S; Hardy RR; Kikutani H; Kishimoto T
J Clin Invest; 1986 Nov; 78(5):1331-8. PubMed ID: 3490495
[TBL] [Abstract][Full Text] [Related]
15. Release of platelet-activating factor (PAF)-like material from human lymphoid cell lines.
Bussolino F; Foa R; Malavasi F; Ferrando ML; Camussi G
Exp Hematol; 1984 Oct; 12(9):688-93. PubMed ID: 6333353
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of a B cell activation factor (BCAF) produced by a human T cell line.
Bowen DL; Ambrus JL; Fauci AS
J Immunol; 1986 Mar; 136(6):2158-63. PubMed ID: 3485143
[TBL] [Abstract][Full Text] [Related]
17. Proliferation of human malignant lymphocytes induced by anti-IgM independent of B cell growth factor.
Baeker TR; Rothstein TL
J Immunol; 1985 May; 134(5):3532-8. PubMed ID: 3872333
[TBL] [Abstract][Full Text] [Related]
18. A thymic stromal cell line supports in vitro development of surface IgM+ B cells and produces a novel growth factor affecting B and T lineage cells.
Friend SL; Hosier S; Nelson A; Foxworthe D; Williams DE; Farr A
Exp Hematol; 1994 Mar; 22(3):321-8. PubMed ID: 8112430
[TBL] [Abstract][Full Text] [Related]
19. Antigenic types of various human lymphoblastoid cell interferons.
Imanishi J; Hoshino S; Matsuoka H; Kishida T; Minowada J
Biken J; 1982 Jun; 25(2):97-100. PubMed ID: 6982706
[TBL] [Abstract][Full Text] [Related]
20. B4, a human B lymphocyte-associated antigen expressed on normal, mitogen-activated, and malignant B lymphocytes.
Nadler LM; Anderson KC; Marti G; Bates M; Park E; Daley JF; Schlossman SF
J Immunol; 1983 Jul; 131(1):244-50. PubMed ID: 6408173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
